MedTrace Logo

Transplantation of Bone Marrow Mesenchymal Stem Cell in Crohn's Disease

NCT01874015 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2017-04-27

No results posted yet for this study

Summary

This study is a prospective, randomized, parallel, phase 1 trial to assess the safety and feasibility of the transplantation of bone marrow derived mesenchymal stem cells (MSCs) in fistulizing Crohn's disease.

Conditions

Interventions

BIOLOGICAL

mesenchymal cell transplantation

Mesenchymal cell transplantation in patients with Crohn's disease.

BIOLOGICAL

mesenchymal cell and fibroblast injection

Transplantation of mesenchymal cell and fibroblast in patients with crohn's disease.

Sponsors & Collaborators

  • Royan Institute

    lead OTHER_GOV

Principal Investigators

  • Hamid Gourabi, PhD · Head of Royan Institute

  • Nasser Aghdami, MD,PhD · Head of Royan department of degenerative medicine,Head of Royan celltherapy center

  • Mahdi Mohammad Nejhad, MD · TUMS DDRI

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2017-12-31
Completion
2018-02-28

Countries

  • Iran

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01874015 on ClinicalTrials.gov